Catherine Eckford2025-11-03T11:59:39
The medicines regulator will aim to take a more flexible licensing approach for the research and manufacture of rare disease therapies in the UK.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-06-22T13:25:00Z
Sponsored by IMA Pharma
2026-06-15T07:55:00Z
Sponsored by Octave, Adam Cross
2026-03-27T15:37:00
Sponsored by IMA Pharma
2026-04-30T10:37:00
Sponsored by Shimadzu
2026-06-29T06:00:00
Sponsored by Lubrizol Advanced Materials Europe BV
2025-10-22T14:00:00
Sponsored by Bruker
2025-12-03T07:58:01
Sponsored by MBV AG
Site powered by Webvision Cloud